New drug shows promise for stubborn bowel disease
NCT ID NCT06626165
Summary
This study tested whether the drug Mirikizumab could help patients with moderate to severe ulcerative colitis who were not getting better on their current treatments. It specifically looked at patients who had a high level of inflammation seen during a colonoscopy. The goal was to see if the drug could improve their symptoms, reduce visible inflammation, and heal the tissue in the colon.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Showa Inan General Hospital
Komagane, Nagano, 399-4117, Japan
Conditions
Explore the condition pages connected to this study.